News | February 04, 2022
Lupin Q3FY22 PAT at Rs 545.52 cr.
Lupin has reported consolidated financial results for the period ended December 31, 2021
Lupin has reported consolidated financial results for the period ended December 31, 2021
The company has reported standalone financial results for the period ended December 31, 2021.
The company has reported total income of Rs. 3715.8 crores during the quarter ended December 31, 2021
Caplin Point Laboratories has reported consolidated financial results for the period ended December 31, 2021.
ICICI Direct analysis of Dr Reddy’s Q3FY22 results
Sun Pharmaceutical Industries has reported consolidated financial results for the period ended December 31, 2021
Dr. Reddy's Laboratories has reported consolidated financial results for the period ended December 31, 2021
Cipla announced its unaudited consolidated financial results for quarter ended December 31st, 2021.
Astec LifeSciences has reported its financial performance for the quarter ended December 31, 2021
Biocon has reported consolidated financial results for the period ended December 31, 2021
Subscribe To Our Newsletter & Stay Updated
